Clinical trial

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

NCT00003680

Drugs and interventions used in this trial

8 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention CMF regimen Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record cyclophosphamide Normalized identity: cyclophosphamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record fluorouracil Normalized identity: fluorouracilView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record methotrexate Normalized identity: methotrexateView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record tamoxifen citrate Normalized identity: tamoxifen citrateView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record thiotepa Normalized identity: thiotepaView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention peripheral blood stem cell transplantation Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention radiation therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date1998-11-01

PhasePHASE3

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

CMF regimenDRUG

cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

fluorouracilDRUG · verified · RxNorm: fluorouracil

methotrexateDRUG · verified · RxNorm: methotrexate

tamoxifen citrateDRUG · verified · RxNorm: tamoxifen citrate

thiotepaDRUG · verified · RxNorm: thiotepa

peripheral blood stem cell transplantationPROCEDURE

radiation therapyRADIATION

Sponsors & collaborators

Scottish Cancer Therapy Networklead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003680 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.